Zobrazeno 1 - 5 of 5 pro vyhledávání: '"Muhanad Abu Elhija"'
1
Akademický článek
Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 Vaccination
Autor: Abdulla Watad, Gabriele De Marco, Hussein Mahajna, Amit Druyan, Mailam Eltity, Nizar Hijazi, Amir Haddad, Muna Elias, Devy Zisman, Mohammad E. Naffaa, Michal Brodavka, Yael Cohen, Arsalan Abu-Much, Muhanad Abu Elhija, Charlie Bridgewood, Pnina Langevitz, Joanna McLorinan, Nicola Luigi Bragazzi, Helena Marzo-Ortega, Merav Lidar, Cassandra Calabrese, Leonard Calabrese, Edward Vital, Yehuda Shoenfeld, Howard Amital, Dennis McGonagle
Publikováno v: Vaccines, Vol 9, Iss 5, p 435 (2021)
Background: Infectious diseases and vaccines can occasionally cause new-onset or flare of immune-mediated diseases (IMDs). The adjuvanticity of the available SARS-CoV-2 vaccines is based on either TLR-7/8 or TLR-9 agonism, which is distinct from prev
Externí odkaz: https://doaj.org/article/3c02d7fb0a1f4615882281e1e3069417
Zobrazit plný text záznamu
2
Implementation of the Treat-to-Target Concept in Evaluation of Psoriatic Arthritis Patients
Autor: Idit Lavi, Muna Elias, Muhanad Abu Elhija, Devy Zisman, Tal Gazitt, Amir Haddad
Publikováno v: Journal of Clinical Medicine; Volume 10; Issue 23; Pages: 5659
Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 10, Iss 5659, p 5659 (2021)
Background: The treat-to-target approach was recently adopted for psoriatic arthritis (PsA) management. Objective: To assess the implementation of the “treat-to-target” (T2T) concept in daily management of PsA by use of composite scores of diseas
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93a689fefbc9bd1d73d3a2a7318a0079
Zobrazit plný text záznamu
3
Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 Vaccination
Autor: Howard Amital, Amit Druyan, Yehuda Shoenfeld, Leonard H. Calabrese, Muhanad Abu Elhija, Gabriele De Marco, Hussein Mahajna, Devy Zisman, Edward M Vital, Nizar Hijazi, Muna Elias, Michal Brodavka, A. Haddad, Abdulla Watad, Dennis McGonagle, Charlie Bridgewood, Joanna McLorinan, Nicola Luigi Bragazzi, Pnina Langevitz, Mailam Eltity, Arsalan Abu-Much, Merav Lidar, Helena Marzo-Ortega, Yael Cohen, Mohammad E. Naffaa, Cassandra Calabrese
Publikováno v: Vaccines
Volume 9
Issue 5
Vaccines, Vol 9, Iss 435, p 435 (2021)
Background: Infectious diseases and vaccines can occasionally cause new-onset or flare of immune-mediated diseases (IMDs). The adjuvanticity of the available SARS-CoV-2 vaccines is based on either TLR-7/8 or TLR-9 agonism, which is distinct from prev
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3213fe69cef6be745865fa47f7ec3d79
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje